Chemical Market Reporter - CLOBETASOL PROPIONATE.
December 14, 1998 -- Chicago, Ill.-based Morton Grove Pharmaceuticals Inc. has received FDA marketing approval for Clobetasol Propionate Topical Solution, USP 5...
Journal of Drugs in Dermatology - Clobetasol propionate for psoriasis: are ointments really more potent?
June 1, 2006 -- Abstract Background: Clobetasol propionate is the most common topical therapy used for psoriasis in the US. Conventional dermatologic wisdom is...
Chain Drug Review - After win in court, Perrigo rolls out clobetasol propionate
April 28, 2008 -- ALLEGAN, Mich. -- Perrigo Co. has launched clobetasol propionate foam. The company took the action after a United States District Court in New Jersey...
PR Newswire - Perrigo Company Receives Final Approval on Clobetasol Propionate Foam
March 11, 2008 -- Court Issues Temporary Restraining Order ALLEGAN, Mich., March 11 /PRNewswire-FirstCall/ -- Perrigo Company today announced that it has received...
Skin & Allergy News - Clobetasol propionate shampoo preferred for scalp psoriasis
October 15, 2002 -- PARIS -- Clobetasol propionate shampoo 0.05% is more effective and cosmetically acceptable than 1% tar shampoo for scalp psoriasis, Dr. Nicholas...
Journal of Drugs in Dermatology - Clobetasol propionate 0.05% lotion in the treatment of moderate to severe atopic dermatitis: a randomized evaluation versus clobetasol propionate emollient...
May 1, 2005 -- Abstract Atopic dermatitis (AD) is a chronic inflammatory and pruritic skin disorder marked by alternating periods of relapse and remission. This...
Journal of Drugs in Dermatology - Treatment of Hailey-Hailey disease with tacrolimus ointment and clobetasol propionate foam
March 1, 2004 -- Abstract Hailey-Hailey disease, or familial benign chronic pemphigus, is a chronic disease without a known cure. Current therapeutic strategies...
Family Pratice News - Clobetasol Propionate Foam Reduced Scalp Psoriasis
May 1, 2000 -- Dr. Stein also compared the bioavailability of a super high-potency topical steroid, clobetasol propionate, in a foam delivery system. The...
Journal of Drugs in Dermatology - In vivo determination of the skin atrophy potential of the super-high-potency topical corticosteroid fluocinonide 0.1% cream compared with clobetasol...
January 1, 2008 -- Abstract Purpose: Prolonged topical corticosteroid use is often associated with atrophic skin changes. This trial compared signs of skin atrophy...
Journal of Drugs in Dermatology - An intra-individual randomized safety and efficacy comparison of clobetasol propionate 0.05% spray and its vehicle in the treatment of plaque psoriasis
April 1, 2006 -- Abstract Background: Plaque psoriasis affects about 2% of the US population. A new and unique spray formulation of clobetasol propionate (CP) 0.05%...
